Hong Kong innovative drug concept stocks collectively opened lower, BeiGene (06160.HK) opened 3.5% lower, Tiger medicine (03347.HK), Kangfang biological (09926.HK) opened more than 2% lower, Fosun medicine (02196.HK) opened 1.91% lower.
Hong Kong biomedical stocks fell again in the afternoon, Junshi Biosciences (01877.HK), Kailaiying (06821.HK) fell more than 7%, Nuocheng Jianhua (09969.HK) fell more than 4.5%, drug combination (02268.HK), Tiger medicine (03347.HK), Kangfang biological (09926.HK) fell more than 3%.
Hong Kong stocks biomedical concept continued to decline in the afternoon, Tiger medicine (03347.HK) fell more than 6%, Junshi Biosciences (01877.HK), WuXi PharmaTech (02359.HK), Zaiding medicine (09688.HK), BeiGene (06160.HK) and other stocks fell.
Spot gold opened today with a minimum test of $3,333. At present, the price has stabilized above 3345. The latest order flow trajectory chart shows that 3346 once experienced a fierce game. Now 3347-3350 active buy orders show advantages. Pay attention to the opportunity for gold prices to rebound further. Click to follow up the latest long and short transaction changes in real time > >
Spot gold rose $15 short-term to $3,347 an ounce.